Alternatives to etanercept
4 same-class SPL records vs etanercept - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Enbrel
How to read a high-report FAERS peer set
etanercept ranks in the upper FAERS-volume third of the corpus (#2 of 524); 4 same-class peers are listed for field comparison only. Labeled indication field for etanercept: Enbrel treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis in adults.
Top FAERS reaction fields for etanercept total 362,627 reports across 10 reactions, set beside adalimumab, certolizumab, golimumab. Counts are exposure-weighted submissions, not per-patient risk.
About etanercept
Enbrel is a medicine that blocks a protein called tumor necrosis factor (TNF). It is used to treat arthritis, psoriasis, and other similar conditions.
Used for: Enbrel treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis in adults. It also treats juvenile idiopathic arthritis, juvenile psoriatic arthritis and plaque psoriasis in children. Enbrel helps to reduce the signs and symptoms of these conditions, like pain and swelling. It can also help to prevent further damage to your joints.
4 TNF-Alpha Inhibitor (Biologic) peers (wide set)
adalimumab
RxHumira
Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
certolizumab
RxCimzia
Cimzia treats Crohn's disease by easing symptoms. It also helps keep the disease under control in adults. Cimzia can also treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis in adults. It is also used for juvenile idiopathic arthritis in children 2 years and older.
golimumab
RxSimponi
Simponi Aria treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. It can help reduce pain, swelling, and stiffness in your joints. For rheumatoid arthritis, you will take this medicine with methotrexate.
infliximab
RxRemicade
Inflectra treats Crohn's disease in adults and children (6+). It helps reduce symptoms and keep the disease under control. It also treats ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
etanercept vs adalimumab & certolizumab · FAERS reaction fields
FAERS top-reaction field "Injection Site Erythema" shows the widest count spread between etanercept and adalimumab, certolizumab, golimumab in this extract (41,016-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | etanercept | adalimumab | certolizumab | golimumab |
|---|---|---|---|---|
| Injection Site Pain | 56,664 | 47,251 | - | - |
| Rheumatoid Arthritis | 46,175 | 35,573 | - | 14,100 |
| Arthralgia | 44,971 | 48,039 | - | 9,679 |
| Pain | 43,004 | 49,062 | - | 13,403 |
| Injection Site Erythema | 41,016 | - | - | - |
| Fatigue | 30,269 | 39,111 | - | 11,277 |
| Pain In Extremity | 25,460 | 24,313 | - | - |
| Joint Swelling | 25,430 | 23,282 | - | 9,729 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
etanercept FAERS volume vs class peers
FAERS volume band
etanercept is FAERS corpus rank #2 of 524 (high volume tercile). Top-reaction field total: 362,627.
Frequently Asked Questions
Where does etanercept sit in FAERS report volume vs TNF-Alpha Inhibitor (Biologic) peers? ▼
Registry note: FAERS counts are voluntary reports and do not establish causation or risk rates. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for etanercept: see also the generic vs brand label guide when reading Enbrel SPL strings.
Read our methodology - how this data is sourced, computed, and verified.